Traditionally, a number of risk factors for BM from MBC have been reported to be associated with high tumor grade, a negative hormone receptor status, early-onset BC, African-American ethnicity, HER2 overexpression or the presence of lung and liver metastases. The gene discussed is ERBB2; the disease is neoplasm.